Screening compound: InChI=1S/C21H27ClN2O3/c22-19-4-2-1-3-18(19)21(26)23-11-7-16(8-12-23)24(20(25)15-5-6-15)17-9-13-27-14-10-17/h1-4,15-17H,5-14H2

Screening compound: InChI=1S/C21H27ClN2O3/c22-19-4-2-1-3-18(19)21(26)23-11-7-16(8-12-23)24(20(25)15-5-6-15)17-9-13-27-14-10-17/h1-4,15-17H,5-14H2
Screening compound: InChI=1S/C21H27ClN2O3/c22-19-4-2-1-3-18(19)21(26)23-11-7-16(8-12-23)24(20(25)15-5-6-15)17-9-13-27-14-10-17/h1-4,15-17H,5-14H2 alternative view

Chemical Structure Depiction of ChemDiv screening compound
InChI=1S/C21H27ClN2O3/c22-19-4-2-1-3-18(19)21(26)23-11-7-16(8-12-23)24(20(25)15-5-6-15)17-9-13-27-14-10-17/h1-4,15-17H,5-14H2

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S329-4842

Molecular Formula

C21H27ClN2O3 (C21 H27 ClN2 O3)

Compound Name

N-[1-(2-chlorobenzoyl)piperidin-4-yl]-N-(oxan-4-yl)cyclopropanecarboxamide

IUPAC name

N-[1-(2-chlorobenzoyl)piperidin-4-yl]-N-(oxan-4-yl)cyclopropanecarboxamide

SMILES

O=C(C1CC1)N(C(CC1)CCN1C(c(cccc1)c1Cl)=O)C1CCOCC1

InChI

InChI=1S/C21H27ClN2O3/c22-19-4-2-1-3-18(19)21(26)23-11-7-16(8-12-23)24(20(25)15-5-6-15)17-9-13-27-14-10-17/h1-4,15-17H,5-14H2

InChI Key

IKVXUCHTOUDBFY-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD31988544

InChI=1S/C21H27ClN2O3/c22-19-4-2-1-3-18(19)21(26)23-11-7-16(8-12-23)24(20(25)15-5-6-15)17-9-13-27-14-10-17/h1-4,15-17H,5-14H2 in Drug Discovery

Included in Screening Libraries

Bromodomain Modulators Library (5801 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

Alpha-Helix Mimetics Library (25899 compounds)

Anti-HIV1 Library (19540 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Mimetics
  • Cyclic compounds
Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system

References: we are preparing a list of scientific research reports with InChI=1S/C21H27ClN2O3/c22-19-4-2-1-3-18(19)21(26)23-11-7-16(8-12-23)24(20(25)15-5-6-15)17-9-13-27-14-10-17/h1-4,15-17H,5-14H2 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound InChI=1S/C21H27ClN2O3/c22-19-4-2-1-3-18(19)21(26)23-11-7-16(8-12-23)24(20(25)15-5-6-15)17-9-13-27-14-10-17/h1-4,15-17H,5-14H2?
Check Price and Availability of InChI=1S/C21H27ClN2O3/c22-19-4-2-1-3-18(19)21(26)23-11-7-16(8-12-23)24(20(25)15-5-6-15)17-9-13-27-14-10-17/h1-4,15-17H,5-14H2, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of InChI=1S/C21H27ClN2O3/c22-19-4-2-1-3-18(19)21(26)23-11-7-16(8-12-23)24(20(25)15-5-6-15)17-9-13-27-14-10-17/h1-4,15-17H,5-14H2 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for InChI=1S/C21H27ClN2O3/c22-19-4-2-1-3-18(19)21(26)23-11-7-16(8-12-23)24(20(25)15-5-6-15)17-9-13-27-14-10-17/h1-4,15-17H,5-14H2
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for InChI=1S/C21H27ClN2O3/c22-19-4-2-1-3-18(19)21(26)23-11-7-16(8-12-23)24(20(25)15-5-6-15)17-9-13-27-14-10-17/h1-4,15-17H,5-14H2
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of InChI=1S/C21H27ClN2O3/c22-19-4-2-1-3-18(19)21(26)23-11-7-16(8-12-23)24(20(25)15-5-6-15)17-9-13-27-14-10-17/h1-4,15-17H,5-14H2 available by request